Prescribing Advice for GPs

An NHS Prescribing Advisers' Blog

Drug Safety Update, Issue 8

The Medicines and Healthcare products Regulatory Agency (MHRA) has published Drug Safety Update Issue 8 (PDF).

This issue includes the following drug safety advice articles:

  • Ketoconazole: restricted indications
  • Telbivudine: risk of peripheral neuropathy with pegylated interferon
  • Modafinil: serious skin reactions, hypersensitivity, and psychiatric symptoms

In addition, this issue contains hot topic information about sales restrictions for nasal decongestants containing pseudoephedrine or ephedrine because of concerns about diversion into the illegal manufacture of methylamphetamine and informs readers of the new and improved electronic Yellow Card for the reporting of suspected adverse drug reactions.

Action: Clinicians will find this publication to be a useful review of current issues in drug safety.

Share 'Drug Safety Update, Issue 8' on Email Share 'Drug Safety Update, Issue 8' on Delicious Share 'Drug Safety Update, Issue 8' on Digg Share 'Drug Safety Update, Issue 8' on Facebook Share 'Drug Safety Update, Issue 8' on Google+ Share 'Drug Safety Update, Issue 8' on reddit Share 'Drug Safety Update, Issue 8' on StumbleUpon Share 'Drug Safety Update, Issue 8' on Twitter

atomic-wealth

No Comments to “Drug Safety Update, Issue 8”

Leave a Comment

(required)

(required)


Prescribing Advice for GPs is powered by WordPress.
Subscribe for Free to our RSS or Atom Feeds for New Entries.
Akismet has protected Prescribing Advice for GPs from 789,520 spam comments.

atomic-wealth
fond-illness
summer